Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data
✍ Scribed by Tom Cornelis; Dimitrios G. Oreopoulos
- Book ID
- 106555486
- Publisher
- Springer Netherlands
- Year
- 2010
- Tongue
- English
- Weight
- 234 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
✦ Synopsis
Encapsulating peritoneal sclerosis (EPS) is an infrequent but serious complication of peritoneal dialysis (PD). The pathogenesis is unknown but speculation is ongoing. The current management of EPS focuses on prevention and treatment of the inflammatory and fibrotic changes at the level of the peritoneal membrane with immunosuppressive and antifibrotic agents, respectively. This article reviews the currently available human and animal data on potential agents to prevent and/or treat EPS. We propose a strategy for early diagnose EPS in an attempt to avoid the development of the full-blown and potentially life-threatening clinical syndrome of EPS. Future research should focus on studying potential prophylactic and therapeutic agents in humans in large, multicenter, randomized trials but also on early detection of EPS in the inflammatory phase by means of biomarkers and the establishment of a composite EPS score.